Condensed Statement of Cash Flows (Unaudited)	7 Months Ended
	Sep. 30, 2021 USD ($)
Cash flow from operating activities:
Net income	$ 1,816,276
Adjustments to reconcile net income to net cash used in operating activities:
Unrealized gain from securities held in Trust Account	(11,591)
Offering costs allocated to warrants	261,838
Change in fair value of warrant liabilities	(2,321,752)
Changes in operating assets and liabilities:
Prepaid insurance	(306,250)
Prepaid expense	(25,755)
Accrued expense	114,401
Net cash used in operating activities	(472,833)
Cash flows from investing activities:
Investment of cash in Trust Account	(117,300,000)
Net cash used in investing activities	(117,300,000)
Cash flow from financing activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from sale of Units, net of underwriting discount paid	113,275,000
Proceeds from sale of private placement units	5,281,750
Payment of offering costs	(478,677)
Net cash provided by financing activities	118,103,073
Net change in cash	330,240
Cash at the beginning of the period
Cash at the end of the period	330,240
Supplemental disclosure of non-cash financing activities:
Deferred underwriting fee payable	4,025,000
Initial classification of Class A common stock subject to redemption	117,300,000
Initial classification of warrant liabilities	5,031,474
Offering costs charged to additional paid-in capital included in accrued expenses	$ 35,000